CH Peptides
Every formulation is curated with lab-grade ingredients, and we're syncing up the freshest data from our inventory so you see accurate availability as soon as the app loads.
Loading live inventory
Syncing 24 research sprays
Verifying lab supplies
Supabase + Stripe ready
Orders placed before 2 P.M. PST Monday through Friday are shipped out same day!
Looks like you haven't added any products to your cart yet.
Loading...
The peptide BPC-157 stands for Body Protection Compound-157. It does not have well-established pharmaceutical development codes outside of this designation. BPC-157 is a synthetic peptide fragment inspired from a protein found in human gastric juice but does not have a direct parent protein from which it is derived in a straightforward manner. Alternative naming conventions in literature predominantly use the abbreviation BPC-157.
BPC-157 consists of 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. The peptide does not have any specific modifications such as N-terminal acetylation or C-terminal amidation. It is a standalone fragment not directly linked to a specific section of a parent protein.
BPC-157's precise receptor targets remain under investigation, but it is hypothesized to interact with growth-promoting pathways and cellular signaling mechanisms. It may influence the vascular endothelial growth factor (VEGF) pathway and nitric oxide (NO) synthesis. Studies suggest potential interactions with pathways such as cAMP/PKA and PI3K/Akt, although exact receptor bindings or EC50/IC50 values are not well-documented in current literature.
It is soluble in sterile water at 1mg/mL. The recommended reconstitution suggests gentle agitation to achieve full dissolution, without vial shaking. The stability of BPC-157 is preserved when lyophilized and it should be stored at -20°C. Reconstituted peptide should be used promptly or stored at 4°C for short-term stability, otherwise re-frozen at -20°C for longer-term preservation.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
The peptide BPC-157 stands for Body Protection Compound-157. It does not have well-established pharmaceutical development codes outside of this designation. BPC-157 is a synthetic peptide fragment inspired from a protein found in human gastric juice but does not have a direct parent protein from which it is derived in a straightforward manner. Alternative naming conventions in literature predominantly use the abbreviation BPC-157.
BPC-157 consists of 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. The peptide does not have any specific modifications such as N-terminal acetylation or C-terminal amidation. It is a standalone fragment not directly linked to a specific section of a parent protein.
BPC-157's precise receptor targets remain under investigation, but it is hypothesized to interact with growth-promoting pathways and cellular signaling mechanisms. It may influence the vascular endothelial growth factor (VEGF) pathway and nitric oxide (NO) synthesis. Studies suggest potential interactions with pathways such as cAMP/PKA and PI3K/Akt, although exact receptor bindings or EC50/IC50 values are not well-documented in current literature.
It is soluble in sterile water at 1mg/mL. The recommended reconstitution suggests gentle agitation to achieve full dissolution, without vial shaking. The stability of BPC-157 is preserved when lyophilized and it should be stored at -20°C. Reconstituted peptide should be used promptly or stored at 4°C for short-term stability, otherwise re-frozen at -20°C for longer-term preservation.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Chorionic Gonadotropin; commonly abbreviated as HCG. It is a glycoprotein hormone composed of alpha and beta subunits, predominantly characterized in human pregnancy. No specific research codes or development codes are associated with the basic glycoprotein.
HCG is a heterodimeric protein composed of two non-covalently linked subunits: the alpha subunit (92 amino acids) shared with other hormones like LH, FSH, and TSH, and the beta subunit (145 amino acids) which is unique to HCG. The beta subunit contains distinct segments: H-Trp-Met-Ser-Glu-His-Ile-Thr-Arg-Tyr-Leu-... and features specific disulfide bridges essential for activity and stability.
HCG acts as an agonist to the luteinizing hormone/chorionic gonadotropin receptor (LHCG receptor). Binding of HCG to its receptor activates pathways such as the cAMP/PKA signaling cascade, promoting steroidogenesis. EC50 values are variable based on assay and cellular system but are indicative of potent agonist activity.
HCG is soluble in sterile water at concentrations of 1mg/mL for research applications. Upon reconstitution, the solution must be stored at 2-8°C and is stable for up to 24 hours. Lyophilized HCG remains stable at -20°C until reconstitution.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Retatrutide is referred to by its research code LY3502970. As of current knowledge, alternative naming conventions in the literature have not been extensively established.
Retatrutide is a peptide compound consisting of 39 amino acids. The exact amino acid sequence is: H-Thr-Lys-Asp-Glu-Leu-Gln-Ala-Ile-Arg-Trp-Leu-Lys-His-Glu-Arg-Asp-His-Gly-Ile-Lys-Lys-Glu-Cys-Leu-Glu-Glu-Val-Leu-Asp-Ser-Leu-Ala-Arg-Ala-Glu-Glu-Arg-OH. Specific modifications include N-terminal acetylation and C-terminal amidation to enhance its activity and stability. It is structurally designed to interact with multiple peptide receptors.
Retatrutide acts as an agonist at multiple receptors, including the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), exhibiting multifaceted activity. Its mechanism enhances several intracellular signaling pathways, notably the cAMP/PKA and PI3K/Akt cascades. It demonstrates a unique binding profile, combining activities that influence metabolic pathways associated with glucose and lipid handling.
Retatrutide is notably soluble in sterile water at a concentration of 1mg/mL. For research applications, it is recommended to reconstitute the lyophilized form in an appropriate buffer and store it at -20°C to maintain stability. Once reconstituted, it remains stable for up to 3 weeks if stored under proper conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Retatrutide is referred to by its research code LY3502970. As of current knowledge, alternative naming conventions in the literature have not been extensively established.
Retatrutide is a peptide compound consisting of 39 amino acids. The exact amino acid sequence is: H-Thr-Lys-Asp-Glu-Leu-Gln-Ala-Ile-Arg-Trp-Leu-Lys-His-Glu-Arg-Asp-His-Gly-Ile-Lys-Lys-Glu-Cys-Leu-Glu-Glu-Val-Leu-Asp-Ser-Leu-Ala-Arg-Ala-Glu-Glu-Arg-OH. Specific modifications include N-terminal acetylation and C-terminal amidation to enhance its activity and stability. It is structurally designed to interact with multiple peptide receptors.
Retatrutide acts as an agonist at multiple receptors, including the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), exhibiting multifaceted activity. Its mechanism enhances several intracellular signaling pathways, notably the cAMP/PKA and PI3K/Akt cascades. It demonstrates a unique binding profile, combining activities that influence metabolic pathways associated with glucose and lipid handling.
Retatrutide is notably soluble in sterile water at a concentration of 1mg/mL. For research applications, it is recommended to reconstitute the lyophilized form in an appropriate buffer and store it at -20°C to maintain stability. Once reconstituted, it remains stable for up to 3 weeks if stored under proper conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.